Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Living Cell Technologies ( (AU:1AI) ) is now available.
Algorae Pharmaceuticals Limited has announced the issuance of 60,000,000 unquoted performance rights as part of previously announced transactions. This move is part of their strategic financial maneuvers and does not involve securities intended to be quoted on the ASX, indicating a focus on internal stakeholder incentives and long-term company growth.
More about Living Cell Technologies
Average Trading Volume: 10,231,180
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$14.34M
Find detailed analytics on 1AI stock on TipRanks’ Stock Analysis page.